Recommended Topic Related To:

Nimbex

"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.

Dotarem is a gadolinium-based"...

Nimbex

Nimbex Patient Information including How Should I Take

What should I discuss with my health care provider before receiving cisatracurium (Nimbex)?

You should not receive this medication if you are allergic to cisatracurium or similar medications used in anesthesia. Also tell your doctor if you are allergic to benzyl alcohol.

Before receiving cisatracurium, tell your doctor if you are allergic to any drugs, or if you have:

  • a muscle disorder such as myasthenia gravis;
  • paralysis in any part of your body;
  • an electrolyte imbalance; or
  • a history of burn injury.

If you have any of these conditions, you may need a dose adjustment or special tests to safely receive this medication.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether cisatracurium passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How is cisatracurium given (Nimbex)?

Cisatracurium is given as an injection through a needle placed into a vein or muscle. You will receive this injection in a hospital or surgical setting.

Your caregivers will monitor your heart function, blood pressure, and breathing while you are under the effects of cisatracurium.

Side Effects Centers
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.